5,703 results on '"hypercalciuria"'
Search Results
2. Stone Disease in Children and Their Families
- Author
-
Linda A Baker, Professor of Urology, Director of Pediatric Urology Research
- Published
- 2024
3. The Impact of Phosphate Metabolism on Healthy Aging
- Author
-
National Center for Advancing Translational Sciences (NCATS)
- Published
- 2024
4. Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population.
- Author
-
Halimi, Caroline, Bor, Clemence, Chieze, Remi, Saint-Jacques, Camille, Périé, Sophie, Wagner, Isabelle, Talbot, Jean-Noel, Montravers, Françoise, Letavernier, Emmanuel, Buob, David, Daudon, Michel, Frochot, Vincent, and Haymann, Jean-Philippe
- Subjects
DIETARY calcium ,PARATHYROID glands ,BONE remodeling ,DYNAMIC testing ,HYPERPARATHYROIDISM ,KIDNEY stones - Abstract
Context Primary hyperparathyroidism (PHPT) is commonly diagnosed in the setting of hypercalcemia, whereas normocalcemic primary hyperparathyroidism (NHPT) may be misdiagnosed. Objective Our objective was to compare patients with hypercalcemic hyperparathyroidism (HPHPT) vs patients with NHPT hypercalciuric renal stones. Methods We took advantage of a routine calcium load test performed in patients with hypercalciuric renal stones to assess retrospectively among patients with PHPT the prevalence and characteristics of NHPT and HPHPT under a calcium-restricted diet Results Among 1671 patients with hypercalciuria, 91 patients had a final diagnosis of PHPT (postload ionized calcium [iCa] > 1.31 mmol/L and parathyroid hormone [PTH] > 30 pg/mL). Prevalence of NHPT is 40% of all PHPT; however, according to total serum calcium, 4/35 NHPT and 7/56 HPHPT cases would have been misclassified in the other group. Eighteen of 35 NHPT and 40/56 HPHPT cases underwent parathyroidectomy. No significant characteristics relating to parathyroid weight, stone composition, or bone remodeling biomarkers were detected between groups. Although iCa is higher in HPHPT in the fasting state and after calcium load, we found no difference for calcium diet, 24-hour calciuria, or calcitriol. Renal calcium excretion postload increased by 303% in NHPT but only 176% in HPHPT (P =.01) likely explained by a lesser PTH decrease (P =.02). However, a strong negative association (P <.0001) detected between pooled preload and postload iCa and PTH only in the NHPT group suggests a persistent efficient PTH-CaSR control within the parathyroid glands in this group. Conclusion Our data show the relevance of dynamic tests to unmask NHPT in patients with hypercalciuric renal stones. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Phytate Effects on Incomplete Distal Renal Tubular Acidosis.
- Author
-
Guimerà, Jordi, Martínez, Ana, Quetglas, José Luis Bauzá, Sanchis, Pilar, Costa-Bauzá, Antonia, Pieras, Enrique, and Grases, Felix
- Subjects
- *
BONE resorption , *PHYTIC acid , *ACIDOSIS , *ORAL drug administration , *URINARY calculi - Abstract
Background: Adults who have incomplete distal renal tubular acidosis (dRTA) may present with recurrent urolithiasis due to metabolic acidosis, leading to bone resorption, which in turn causes hypercalciuria and urine alkalinization (pH > 6.0). Oral potassium citrate is the most commonly used treatment for dRTA, but some patients cannot tolerate this treatment. The objective of this single-arm study was to evaluate the effect of phytate, an inhibitor of bone resorption, on calciuria of patients with incomplete dRTA. Methods: The calciuria levels of 16 patients who had incomplete dRTA with urolithiasis and could not tolerate potassium citrate treatment were recorded before (baseline) and after 6 months of treatment with oral calcium magnesium phytate (380 mg every 12 h). There were no dietary modifications or other treatments. Results: The baseline calciuria was 317 ± 81 mg/24 h and the level after 6 months was 221 ± 38 mg/24 h (p < 0.005). Conclusions: Our results suggest that calcium magnesium phytate should be considered as an alternative or adjunctive treatment for hypercalciuria in patients with incomplete dRTA. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis.
- Author
-
Zhu, Wei, Zhou, Zhen, Wu, Chengjie, Huang, Zhicong, Zhao, Ruiyue, Wang, Xinlu, Luo, Lianmin, Liu, Yang, Zhong, Wen, Zhao, Zhijian, Ai, Guoyao, Zhong, Jian, Liu, Shusheng, Liu, Weijie, Pang, Xuliang, Sun, Yin, and Zeng, Guohua
- Subjects
- *
CALCITONIN receptors , *LABORATORY rats , *KIDNEY stones , *GENE expression , *IDIOPATHIC diseases , *CALCITONIN - Abstract
Calcium-containing stones represent the most common form of kidney calculi, frequently linked to idiopathic hypercalciuria, though their precise pathogenesis remains elusive. This research aimed to elucidate the molecular mechanisms involved by employing urinary exosomal microRNAs as proxies for renal tissue analysis. Elevated miR-148b-5p levels were observed in exosomes derived from patients with kidney stones. Systemic administration of miR-148b-5p in rat models resulted in heightened urinary calcium excretion, whereas its inhibition reduced stone formation. RNA immunoprecipitation combined with deep sequencing identified miR-148b-5p as a suppressor of calcitonin receptor (Calcr) expression, thereby promoting urinary calcium excretion and stone formation. Mice deficient in Calcr in distal epithelial cells demonstrated elevated urinary calcium excretion and renal calcification. Mechanistically, miR-148b-5p regulated Calcr through the circRNA-83536/miR-24-3p signaling pathway. Human kidney tissue samples corroborated these results. In summary, miR-148b-5p regulates the formation of calcium-containing kidney stones via the circRNA-83536/miR-24-3p/Calcr axis, presenting a potential target for novel therapeutic interventions to prevent calcium nephrolithiasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Clinical features and genetic analysis of 15 Chinese children with dent disease.
- Author
-
Li, Qian, Yang, Zhenle, Zang, Ruixian, Liu, Suwen, Yu, Lichun, Wang, Jing, Wang, Cong, Wang, Xiaoyuan, and Sun, Shuzhen
- Subjects
- *
CHINESE people , *JUVENILE diseases , *FOCAL segmental glomerulosclerosis , *FRAMESHIFT mutation , *NONSENSE mutation , *RENAL tubular transport disorders - Abstract
The clinical characteristics, genetic mutation spectrum, treatment strategies and prognoses of 15 children with Dent disease were retrospectively analyzed to improve pediatricians' awareness of and attention to this disease. We analyzed the clinical and laboratory data of 15 Chinese children with Dent disease who were diagnosed and treated at our hospital between January 2017 and May 2023 and evaluated the expression of the CLCN5 and OCRL1 genes. All 15 patients were male and complained of proteinuria, and the incidence of low-molecular-weight proteinuria (LMWP) was 100.0% in both Dent disease 1 (DD1) and Dent disease 2 (DD2) patients. The incidence of hypercalciuria was 58.3% (7/12) and 66.7% (2/3) in DD1 and DD2 patients, respectively. Nephrocalcinosis and nephrolithiasis were found in 16.7% (2/12) and 8.3% (1/12) of DD1 patients, respectively. Renal biopsy revealed focal segmental glomerulosclerosis (FSGS) in 1 patient, minimal change lesion in 5 patients, and small focal acute tubular injury in 1 patient. A total of 11 mutations in the CLCN5 gene were detected, including 3 missense mutations (25.0%, c.1756C > T, c.1166T > G, and c.1618G > A), 5 frameshift mutations (41.7%, c.407delT, c.1702_c.1703insC, c.137delC, c.665_666delGGinsC, and c.2200delG), and 3 nonsense mutations (25.0%, c.776G > A, c.1609C > T, and c.1152G > A). There was no significant difference in age or clinical phenotype among patients with different mutation types (p > 0.05). All three mutations in the OCRL1 gene were missense mutations (c.1477C > T, c.952C > T, and c.198A > G). Pediatric Dent disease is often misdiagnosed. Protein electrophoresis and genetic testing can help to provide an early and correct diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Metabolic Risk Factors in Children with Urinary System Stones.
- Author
-
Çivilibal, Mahmut, Çivilibal, Ata Mert, and Sılay, Mesrur Selçuk
- Subjects
URINARY calculi ,CHILD patients ,THERAPEUTICS ,PEDIATRIC nephrology ,URINARY organs ,RENAL colic - Abstract
Objective: To diagnose, treat, and prevent stone recurrence, it is important to determine the metabolic risk factors that play a role in developing urinary system stone disease in children. This study assessed children with urinary system stones’ clinical, radiological, and metabolic characteristics. Material And Methods: A retrospective study was conducted on the records of pediatric patients who applied to our pediatric outpatient nephrology clinic for various reasons between February 2018 and December 2023 and were diagnosed with urinary system stones. Results: Of the 122 patients with a mean age of 4.40±4.16 years (1 month-17 years), 63 (51.6%) were boys and 59 (48.4%) were girls. In 61.4% of the children, a family history was identified. The most common presenting symptom was abdominal/flank pain or restlessness (47.5%). In 25.4% of the patients, the stones were ≤3 mm (microlithiasis), and most stones were in the upper system. One or more metabolic abnormalities have been detected during urine analysis for 58.2% of patients. The most frequent metabolic abnormalities were hypercalciuria (20.5%) and hypocitraturia (17.2%). In 74.6% of patients, the size of stones decreased or completely disappeared with medical treatment based on underlying metabolic abnormalities, and in 17.2%, they did not change at all. Only eight (6.6%) patients required interventional procedures. Conclusion: Metabolic causes should be investigated first in all children with urinary tract stones. Special medical treatments designed to alter metabolism reduce the need for invasive stone procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation.
- Author
-
Gombedza, Farai C., Shin, Samuel, Sadiua, Jaclyn, Stackhouse, George B., and Bandyopadhyay, Bidhan C.
- Subjects
- *
MIXED crystals , *CALCIUM , *TRP channels , *CALCIUM channels , *CALCIUM oxalate , *GENE expression profiling , *KIDNEY stones - Abstract
In calcium nephrolithiasis (CaNL), most calcium kidney stones are identified as calcium oxalate (CaOx) with variable amounts of calcium phosphate (CaP), where CaP is found as the core component. The nucleation of CaP could be the first step of CaP+CaOx (mixed) stone formation. High urinary supersaturation of CaP due to hypercalciuria and an elevated urine pH have been described as the two main factors in the nucleation of CaP crystals. Our previous in vivo findings (in mice) show that transient receptor potential canonical type 3 (TRPC3)-mediated Ca2+ entry triggers a transepithelial Ca2+ flux to regulate proximal tubular (PT) luminal [Ca2+], and TRPC3-knockout (KO; -/-) mice exhibited moderate hypercalciuria and microcrystal formation at the loop of Henle (LOH). Therefore, we utilized TRPC3 KO mice and exposed them to both hypercalciuric [2% calcium gluconate (CaG) treatment] and alkalineuric conditions [0.08% acetazolamide (ACZ) treatment] to generate a CaNL phenotype. Our results revealed a significant CaP and mixed crystal formation in those treated KO mice (KOT) compared to their WT counterparts (WTT). Importantly, prolonged exposure to CaG and ACZ resulted in a further increase in crystal size for both treated groups (WTT and KOT), but the KOT mice crystal sizes were markedly larger. Moreover, kidney tissue sections of the KOT mice displayed a greater CaP and mixed microcrystal formation than the kidney sections of the WTT group, specifically in the outer and inner medullary and calyceal region; thus, a higher degree of calcifications and mixed calcium lithiasis in the kidneys of the KOT group was displayed. In our effort to find the Ca2+ signaling pathophysiology of PT cells, we found that PT cells from both treated groups (WTT and KOT) elicited a larger Ca2+ entry compared to the WT counterparts because of significant inhibition by the store-operated Ca2+ entry (SOCE) inhibitor, Pyr6. In the presence of both SOCE (Pyr6) and ROCE (receptor-operated Ca2+ entry) inhibitors (Pyr10), Ca2+ entry by WTT cells was moderately inhibited, suggesting that the Ca2+ and pH levels exerted sensitivity changes in response to ROCE and SOCE. An assessment of the gene expression profiles in the PT cells of WTT and KOT mice revealed a safeguarding effect of TRPC3 against detrimental processes (calcification, fibrosis, inflammation, and apoptosis) in the presence of higher pH and hypercalciuric conditions in mice. Together, these findings show that compromise in both the ROCE and SOCE mechanisms in the absence of TRPC3 under hypercalciuric plus higher tubular pH conditions results in higher CaP and mixed crystal formation and that TRPC3 is protective against those adverse effects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Hybrid kidney stones physicochemical and morphological characterization: A spectroscopic study analysis
- Author
-
Asma Ahmad, Ghazala Mustafa, and Murtaza Hasan
- Subjects
Metabolic evaluation ,Nephrolithiasis ,Hypercalciuria ,Hyperuricosuria ,Hyperoxaluria ,Hypocitraturia ,Technology - Abstract
This study was designed to scrutinize the practical health index of uroliths for investigating composition, structural characterization, phase quantification and shape of kidney stone patients with respect to socioeconomically status in territory of Bahawalpur, southern Punjab, Pakistan. Morphology of the kidney stones were determined using SEM. The Ultra violet spectra of kidney stones in narrow range of 220–280 nm. Quantitative phase analysis of stones indicates as oxalate, calcium oxalate monohydrate, calcium oxalate dehydrates, calcium phosphate, cysteine and uric acid with 40.51 %, 26.24 %, 14.24 %, 36.45 %,13.18 % and 9.86 % respectively. A survey analysis also supports the vitro data showing patient age with 30–40 years with more predominance in males than females. Metabolic abnormalities were detected in 75 % patients with stone recurrence 15 % complained of having digestive disease. The overall concludes from qualitative and quantitative results suggested the community for preventive measures in reducing the risk of pervasiveness and relapse of urolithiasis.
- Published
- 2024
- Full Text
- View/download PDF
11. Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria (RICHH)
- Author
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Published
- 2023
12. National Registry of Rare Kidney Diseases (RaDaR)
- Published
- 2023
13. Effects of SLC34A3 or SLC34A1 variants on calcium and phosphorus homeostasis
- Author
-
Naciri Bennani, Hamza, Chtioui, Imane, Allirot, Camille, Somrani, Rim, Jouve, Thomas, Rostaing, Lionel, and Bourdat-Michel, Guylhene
- Published
- 2024
- Full Text
- View/download PDF
14. Hipouricemia con hipercalciuria. Estudio longitudinal y revisión del tema
- Author
-
Teresa Moraleda Mesa, Cristina de la Torre Sandoval, Sara Duque González, Ana Karina Rolo Álvarez, María Isabel Luis Yanes, and Víctor M. García Nieto
- Subjects
Hypercalciuria ,Hypouricemia ,Bone mineral density ,Urate tubular reabsorption ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Resumen: Antecedentes y objetivo: La asociación de hipouricemia e hipercalciuria es poco frecuente. En 1974 se describió un nuevo síndrome nominado Hipouricemia con hipercalciuria y reducción de la densidad ósea. Posteriormente, se publicaron algunos casos con esa asociación en los que la excreción fraccional de urato era superior a 20/100 ml FGR. Hemos analizado una serie de niños que fueron diagnosticados de hipouricemia e hipercalciuria y que fueron controlados evolutivamente. El objetivo del trabajo es intentar conocer si nuestros pacientes podrían estar afectos del síndrome antes mencionado o ser portadores de una variante de hipercalciuria idiopática. Pacientes y métodos: Estudio retrospectivo longitudinal en el que se estudiaron las historias clínicas de 8 pacientes (5 V y 3 M) diagnosticados de hipouricemia e hipercalciuria en la infancia. Se anotaron la clínica al diagnóstico, los hallazgos ecográficos y densitométricos, y determinadas variables bioquímicas, con especial hincapié en el manejo tubular renal del urato. Los resultados se compararon con los de 36 niños afectos de hipercalciuria idiopática sin hipouricemia (14 V y 22 M). Resultados: En el grupo con hipouricemia los niveles iniciales de uricemia fueron 1,9 (0,3) mg/dl (rango: 1,5-2) y los del cociente calcio/creatinina en primera orina del día, 0,27 (0,05) mg/mg (rango: 0,23-0,31). En todos los casos la excreción fraccional de urato fue inferior a 20 ml/100 ml FGR. Los valores de z-DMO fueron menores de −1 en 4/8 casos. En el último control, solo en 3 casos persistía el cociente calcio/creatinina elevado, y en todos la uricemia era superior a 2 mg/dl. El valor de z-DMO había mejorado en 5 casos y empeorado en otros 3. En relación con el grupo sin hipouricemia, no se observaron diferencias entre los diversos parámetros estudiados incluido el valor de z-DMO, con la excepción de la excreción fraccional y la reabsorción tubular de urato, aunque los niveles de uricemia seguían siendo significativamente inferiores. Conclusión: Nuestros pacientes con hipercalciuria e hipouricemia estarían afectos de una variante de hipercalciuria idiopática en la que por causa desconocida la reabsorción tubular proximal de urato está reducida discretamente y mejora con el tiempo. Es posible que el síndrome de Hipouricemia con hipercalciuria y reducción de la densidad ósea no sea una entidad específica. Abstract: Background and objective: The association of hypouricemia and hypercalciuria is rare. In 1974 a new syndrome named Hypouricemia with hypercalciuria and decreased bone density was described. Afterwards, some cases with such association were published in which the fractional excretion of urate was higher than 20/100 ml FGR. We have analyzed a series of children who were diagnosed with hypouricemia and hypercalciuria and who were monitored. The aim of this study was to determine whether our patients could be affected by the aforementioned syndrome or be carriers of a variant of idiopathic hypercalciuria. Patients and methods: Retrospective longitudinal study in which the medical records of eight patients (5 V and 3 M) diagnosed with hypouricemia and hypercalciuria in childhood. Clinical features at diagnosis, ultrasound and densitometric findings and selected biochemical variables were noted, with special emphasis on renal tubular handling of urate. Results were compared with 36 children with idiopathic hypercalciuria without hypouricemia (14 V and 22 M). Results: In the hypouricemia group baseline urate levels were 1.9 (0.3) mg/dl (range: 1.5-2) and first day urine calcium/creatinine ratio 0.27 (0.05) mg/mg (range: 0.23-0.31). In all cases fractional urate excretion was less than 20/100 ml FGR. The z-DMO values were less than −1 in 4/8 cases. At the last follow-up only three cases still had an elevated calcium/creatinine ratio and in all of them the urates levels was greater than 2 mg/dl. The z-DMO value had improved in five cases and worsened in three others. In relation to the group without hypouricemia, no differences were observed between the various parameters studied including the z-DMO value, with the exception of fractional excretion and tubular urate reabsorption although plasmatic uric acid levels were still significantly lower. Conclusion: Our patients with hypercalciuria and hypouricemia would be affected by a variant of idiopathic hypercalciuria in which, due to an unknown cause, the proximal tubular reabsorption of urate is modestly reduced and improves over time. Hypouricemia with hypercalciuria and decreased bone density may not be a specific entity.
- Published
- 2024
- Full Text
- View/download PDF
15. Family analysis and literature study of hereditary hypophosphatemic rickets with hypercalciuria
- Author
-
Lufeng Wang, Gulimire Kulaixi, Jiazireya Zaiyinati, Guzhalikezi Aibai, Danyang Du, and Yanying Guo
- Subjects
HHRH ,SLC34A3 ,Hypophosphatemia ,Nephrocalcinosis ,Hypercalciuria ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Hereditary hypophosphatemia rickets with hypercalciuria (HHRH) is a rare autosomal recessive disorder characterised by reduced renal phosphate reabsorption leading to hypophosphataemia, rickets and bone pain. Here, we present a case of HHRH in a Chinese boy. Case presentation We report a 11-year-old female proband, who was admitted to our hospital with bilateral genuvarum deformity and short stature. Computed Tomography (CT) showed kidney stones, blood tests showed hypophosphatemia, For a clear diagnosis, we employed high-throughput sequencing technology to screen for variants. Our gene sequencing approach encompassed whole exome sequencing, detection of exon and intron junction regions, and examination of a 20 bp region of adjacent introns. Flanking sequences are defined as ±50 bp upstream and downstream of the 5′ and 3′ ends of the coding region.The raw sequence data were compared to the known gene sequence data in publicly available sequence data bases using Burrows-Wheeler Aligner software (BWA, 0.7.12-r1039), and the pathogenic variant sites were annotated using Annovar. Subsequently, the suspected pathogenic variants were classified according to ACMG’s gene variation classification system. Simultaneously, unreported or clinically ambiguous pathogenic variants were predicted and annotated based on population databases. Any suspected pathogenic variants identified through this analysis were then validated using Sanger sequencing technology. At last, the proband and her affected sister carried pathogenic homozygous variant in the geneSLC34A3(exon 13, c.1402C > T; p.R468W). Their parents were both heterozygous carriers of the variant. Genetic testing revealed that the patient has anLRP5(exon 18, c.3917C > T; p.A1306V) variant of Uncertain significance, which is a rare homozygous variant. Conclusion This case report aims to raise awareness of the presenting characteristics of HHRH. The paper describes a unique case involving variants in both theSLC34A3andLRP5genes, which are inherited in an autosomal recessive manner. This combination of gene variants has not been previously reported in the literature. It is uncertain whether the presence of these two mutated genes in the same individual will result in more severe clinical symptoms. This report shows that an accurate diagnosis is critical, and with early diagnosis and correct treatment, patients will have a better prognosis.
- Published
- 2024
- Full Text
- View/download PDF
16. Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
- Published
- 2023
17. Clinical features and genetic analysis of 15 Chinese children with dent disease
- Author
-
Qian Li, Zhenle Yang, Ruixian Zang, Suwen Liu, Lichun Yu, Jing Wang, Cong Wang, Xiaoyuan Wang, and Shuzhen Sun
- Subjects
Dent disease ,CLCN 5 gene ,OCRL1 gene ,low-molecular-weight proteinuria ,hypercalciuria ,children ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Objective The clinical characteristics, genetic mutation spectrum, treatment strategies and prognoses of 15 children with Dent disease were retrospectively analyzed to improve pediatricians’ awareness of and attention to this disease.Methods We analyzed the clinical and laboratory data of 15 Chinese children with Dent disease who were diagnosed and treated at our hospital between January 2017 and May 2023 and evaluated the expression of the CLCN5 and OCRL1 genes.Results All 15 patients were male and complained of proteinuria, and the incidence of low-molecular-weight proteinuria (LMWP) was 100.0% in both Dent disease 1 (DD1) and Dent disease 2 (DD2) patients. The incidence of hypercalciuria was 58.3% (7/12) and 66.7% (2/3) in DD1 and DD2 patients, respectively. Nephrocalcinosis and nephrolithiasis were found in 16.7% (2/12) and 8.3% (1/12) of DD1 patients, respectively. Renal biopsy revealed focal segmental glomerulosclerosis (FSGS) in 1 patient, minimal change lesion in 5 patients, and small focal acute tubular injury in 1 patient. A total of 11 mutations in the CLCN5 gene were detected, including 3 missense mutations (25.0%, c.1756C > T, c.1166T > G, and c.1618G > A), 5 frameshift mutations (41.7%, c.407delT, c.1702_c.1703insC, c.137delC, c.665_666delGGinsC, and c.2200delG), and 3 nonsense mutations (25.0%, c.776G > A, c.1609C > T, and c.1152G > A). There was no significant difference in age or clinical phenotype among patients with different mutation types (p > 0.05). All three mutations in the OCRL1 gene were missense mutations (c.1477C > T, c.952C > T, and c.198A > G).Conclusion Pediatric Dent disease is often misdiagnosed. Protein electrophoresis and genetic testing can help to provide an early and correct diagnosis.
- Published
- 2024
- Full Text
- View/download PDF
18. A previously healthy 3-year-old female with hypertension, proteinuria, and hypercalciuria.
- Author
-
Liu, Tao, Wang, Wenhong, Liu, Zhufeng, Pei, Guanghua, Wang, Chunxiang, Jiang, Ying, and Pang, Chuyue
- Subjects
- *
TREATMENT of rare diseases , *CRANIAL radiography , *HYPERTENSION , *MAGNETIC resonance angiography , *ECHOCARDIOGRAPHY , *GENETIC mutation , *GENETIC testing , *PROTEINURIA , *COMPUTED tomography , *HYPERCALCIUREA , *RARE diseases - Abstract
A 3-year-old female patient with no significant medical history presented to her pediatrician with foamy urine. Initial testing revealed moderate proteinuria on qualitative testing, although she was incidentally noted to have severe hypertension (240/200 mmHg). Physical examination of the carotid and femoral areas revealed significant systolic vascular murmurs. Labs showed elevated serum creatinine, hypokalemia, metabolic alkalosis, elevated renin and aldosterone and hypercalciuria. Echocardiography identified ventricular hypertrophy. Computed tomography (CT) of the abdomen and magnetic resonance angiography of the head showed multiple tortuous or interrupted arteries and multiple calcifications in the renal sinus area. B-mode ultrasonography suggested thickening of the carotid and femoral artery walls, with numerous spotted calcifications. Genetic testing revealed that ABCC6 had a complex heterozygous mutation (exon 24: c.3340C > T and intron 30: c.4404-1G > A). Our panel of experts reviewed the evaluation of this patient with hypertension, proteinuria, hypercalciuria, and vascular abnormalities as well as the diagnosis and appropriate management of a rare disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Kidney involvement in Wilson's disease: a review of the literature.
- Author
-
Dang, Julien, Chevalier, Kevin, Letavernier, Emmanuel, Tissandier, Come, Mouawad, Sarah, Debray, Dominique, Obadia, Mickaël, and Poujois, Aurélia
- Subjects
- *
HEPATOLENTICULAR degeneration , *LITERATURE reviews , *RENAL tubular transport disorders , *HEPATORENAL syndrome , *GENETIC disorders , *FANCONI syndrome , *NEPHROTOXICOLOGY - Abstract
Wilson's disease (WD) is a rare inherited disease due to the mutation of the ATP7B gene, resulting in impaired hepatic copper excretion and its pathological accumulation in various organs such as the liver, the nervous system, or the kidneys. Whereas liver failure and neuropsychiatric disorders are the most common features, less is known about the renal complications. We conducted a review of the literature to define the characteristics and pathophysiology of kidney involvement during WD. This review shed light on strong evidence for direct copper toxicity to renal tubular cells. Excessive tubular copper accumulation might present with various degrees of tubular dysfunction, ranging from mild hydroelectrolytic and acid–base disorders to complete Fanconi syndrome. Proximal and distal renal tubular acidosis also favors development of nephrolithiasis, nephrocalcinosis, and bone metabolism abnormalities. Indirect complications might involve renal hypoperfusion as occurs in hepatorenal or cardiorenal syndrome, but also tubular casts' formation during acute hemolysis, rhabdomyolysis, or bile cast nephropathy. Acute kidney failure is not uncommon in severe WD patients, and independently increases mortality. Finally, specific and long-term therapy by D-penicillamin, one of the most efficient drugs in WD, can cause glomerular injuries, such as membranous nephropathy, minimal-change disease, and, rarely, severe glomerulonephritis. Altogether, our study supports the need for interdisciplinary evaluation of WD patients involving nephrologists, with regular monitoring of tubular and glomerular functions, to provide adequate prevention of renal and bone involvement. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D.
- Author
-
Mohan, Sneha, Sheehan, Michael, Tebben, Peter, and Wermers, Robert
- Subjects
- *
HYPERCALCEMIA , *HYPOPARATHYROIDISM , *GENETIC mutation , *GENETIC testing , *WHITE men , *KIDNEY stones - Abstract
Elevated 1,25-dihydroxyvitamin D (1,25(OH)2D) is a rare cause of non–parathyroid hormone (PTH)–mediated hypercalcemia seen in granulomatous disease, malignancy (most often lymphoma), or genetic mutations. Therapeutic options are limited. We report the case of a 67-year-old White man with nonmalignant, nongranulomatous, 1,25(OH)2D-mediated hypercalcemia treated successfully with cinacalcet. At presentation, he had hypercalcemia, hypercalciuria with recurrent nephrolithiasis, low PTH, elevated 1,25(OH)2D, and normal 25-hydroxyvitamin D. The 1,25(OH)2D levels were inappropriate in the setting of hypercalcemia with low PTH. Evaluations for sarcoidosis, tuberculosis, and malignancy were negative. Genetic testing showed biallelic variants in the CYP24A1 gene. Cinacalcet was trialed and showed normalization of calcium levels. On cinacalcet, biochemical indices showed a slight increase in 1,25(OH)2D and 24-hour urine calcium and mild decrease in PTH. He briefly experienced symptomatic hypocalcemia that resolved after reducing cinacalcet dose. Due to limited symptomatic benefit, he opted to stop cinacalcet. Additional follow-up showed intermittently elevated serum calcium levels after stopping cinacalcet, most recently 10.3 mg/dL. Cinacalcet may be a therapeutic option in nonmalignant, 1,25(OH)2D-mediated hypercalcemia. Further study is necessary to confirm efficacy, understand risks and benefits, and elucidate mechanism(s) of action. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Urinary excretion of calcium, phosphate, magnesium, and uric acid in healthy infants and young children. Influence of feeding practices in early infancy.
- Author
-
Peris Vidal, Amelia, Ferrando Monleón, Susana, Marín Serra, Juan, Quiñones-Torrelo, Carmen, Hervás Andrés, Aurelio, Fons Moreno, Jaime, and Hernández Marco, Roberto
- Subjects
- *
BREASTFEEDING techniques , *REFERENCE values , *STATISTICS , *ANALYSIS of variance , *SOFTWARE architecture , *MAGNESIUM , *DESCRIPTIVE statistics , *CALCIUM , *DIETARY calcium , *URIC acid , *STATISTICAL models , *DATA analysis , *HYPERCALCIUREA , *CREATININE , *PHOSPHATES , *CHILDREN - Abstract
Background: Reference values for urinary calcium (Ca) and other solutes/creatinine (Cr) ratios in infants and young children are scarce. Its variation with type of lactation administered, breastfed (BF) or formula (F), is incompletely known. Methods: A total of 511 spot urine samples from 136 children, aged 6 days to < 5 years, was collected. Urine was collected no fasting in infants < 18 months and first morning fasting in children aged 2.5–4 years. Urinary osmolality, Cr, urea, Ca, phosphate (P), magnesium (Mg), and uric acid (UA) were determined. Values are expressed as solute-to-Cr ratio. Results: Urinary values were grouped according to the child's age: 6–17 days (G1), 1–5 months (G2), 6–12 months (G3), 13–18 months (G4), and 2.5–4 years (G5). G1 was excluded; Ca/Cr and UA/Cr (95th percentile) decreased with age (G2 vs. G5) from 1.64 to 0.39 and 2.33 to 0.83 mg/mg, respectively. The P/Cr median rises significantly with age from 0.31 (G2) to 1.66 mg/mg (G5). Mg/Cr was similar in all groups (median 0.20, 95th percentile 0.37 mg/mg). Ca/Cr (95th percentile) of BF infants was 1.80 mg/mg (< 3 months) and 1.63 mg/mg (3–5 months), much higher than F infants (0.93 and 0.90 mg/mg, respectively). P/Cr and P/Ca were lower in BF infants. Conclusions: Values for urinary Ca/Cr, P/Cr, Mg/Cr, and UA/Cr in infants and children < 5 years were updated. BF infants < 6 months showed higher Ca/Cr and lower P/Cr than F infants. New cutoff values to diagnose hypercalciuria in infants < 6 months, according to the type of lactation, are proposed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Ca2+ 诱导HK-2细胞焦亡及黏附性变化对含钙 肾结石形成的分子机制研究.
- Author
-
向近杰, 吕懋鑫, 王梦悦, 张坤, and 李颢
- Abstract
Objective To investigate the possible role and mechanism of activation of pyroptosis classical pathway and alterations in cell adhesion in calcium-containing kidney stones after the action of high concentration of Ca2+ on HK-2 cells. Methods HK-2 cells were cultured in the presence of different concentrations of CaCl2 (0, 0.1, 0.5, 1.0, 2.0, 4.0 and 8.0 g/L) for 24 hours, and cell counting Kit-8 (CCK-8) and flow cytometry were used to determine the optimal treatment concentration. Subsequently, the ultrastructure of renal tubular epithelial cells under high Ca2+ condition was observed by transmission electron microscopy after Ca2+ treatment. DCFH-DA staining was used to detect intracellular reactive oxygen species production, and quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot analysis were performed to examine the expression of pyroptosis-related proteins NLRP3, Caspase-1, gasdermin D (GSDMD), adhesive molecules osteopontin (OPN) and CD44 at mRNA and protein levels after high concentration Ca2+ treatment. The expression levels of pyroptosis-related inflammatory factors interleukin (IL)-1β, IL-18 and adhesive molecule monocyte chemotactic protein-1 (MCP-1) were detected by enzyme-linked immunosorbent assay (ELISA) after high Ca2+ stimulation. Results Ca2+ showed cytotoxicity for HK-2 cell growth and can promote apoptosis. The higher the Ca2+ concentration, the more toxicity and apoptosis rate for HK-2 cell growth. High concentration of Ca2+ can promote pyroptosis-like morphological changes in HK-2 cells, including loss of cell membrane integrity, release of contents and numerous intracellular vacuoles. Compared with the control group, the expression levels of ROS were sequentially increased in the 1.0 g/L CaCl2 group and the 2.0 g/L CaCl2 group, and the expression levels of pyroptosis-related genes NLRP3, Caspase-1, GSDMD, and the pyroptosis-associated inflammatory factors IL-1β and IL-18, as well as the adhesion molecules OPN, CD44 and MCP-1 were significantly increased (P<0.05). Conclusion High Ca2+ treatment can cause oxidative stress damage in HK-2 cells to produce ROS, which activates NLRP3 inflammasome, leads to the activation of the classical pathway of pyroptosis and increase the adhesion of cells, and ultimately leads to the formation of kidney stones. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Hipouricemia con hipercalciuria. Estudio longitudinal y revisión del tema.
- Author
-
Moraleda Mesa, Teresa, de la Torre Sandoval, Cristina, Duque González, Sara, Rolo Álvarez, Ana Karina, Luis Yanes, María Isabel, and García Nieto, Víctor M.
- Abstract
Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
24. Family analysis and literature study of hereditary hypophosphatemic rickets with hypercalciuria.
- Author
-
Wang, Lufeng, Kulaixi, Gulimire, Zaiyinati, Jiazireya, Aibai, Guzhalikezi, Du, Danyang, and Guo, Yanying
- Subjects
RICKETS ,GENETIC variation ,CONSCIOUSNESS raising ,GENETIC testing ,SHORT stature ,HYPOPHOSPHATEMIA - Abstract
Background: Hereditary hypophosphatemia rickets with hypercalciuria (HHRH) is a rare autosomal recessive disorder characterised by reduced renal phosphate reabsorption leading to hypophosphataemia, rickets and bone pain. Here, we present a case of HHRH in a Chinese boy. Case presentation: We report a 11-year-old female proband, who was admitted to our hospital with bilateral genuvarum deformity and short stature. Computed Tomography (CT) showed kidney stones, blood tests showed hypophosphatemia, For a clear diagnosis, we employed high-throughput sequencing technology to screen for variants. Our gene sequencing approach encompassed whole exome sequencing, detection of exon and intron junction regions, and examination of a 20 bp region of adjacent introns. Flanking sequences are defined as ±50 bp upstream and downstream of the 5′ and 3′ ends of the coding region.The raw sequence data were compared to the known gene sequence data in publicly available sequence data bases using Burrows-Wheeler Aligner software (BWA, 0.7.12-r1039), and the pathogenic variant sites were annotated using Annovar. Subsequently, the suspected pathogenic variants were classified according to ACMG's gene variation classification system. Simultaneously, unreported or clinically ambiguous pathogenic variants were predicted and annotated based on population databases. Any suspected pathogenic variants identified through this analysis were then validated using Sanger sequencing technology. At last, the proband and her affected sister carried pathogenic homozygous variant in the geneSLC34A3(exon 13, c.1402C > T; p.R468W). Their parents were both heterozygous carriers of the variant. Genetic testing revealed that the patient has anLRP5(exon 18, c.3917C > T; p.A1306V) variant of Uncertain significance, which is a rare homozygous variant. Conclusion: This case report aims to raise awareness of the presenting characteristics of HHRH. The paper describes a unique case involving variants in both theSLC34A3andLRP5genes, which are inherited in an autosomal recessive manner. This combination of gene variants has not been previously reported in the literature. It is uncertain whether the presence of these two mutated genes in the same individual will result in more severe clinical symptoms. This report shows that an accurate diagnosis is critical, and with early diagnosis and correct treatment, patients will have a better prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium
- Author
-
David S. Goldfarb, M.D., PI
- Published
- 2023
26. Assessing the Impact of a Mode of Vitamin D Supplementation (Sequential Dose vs Daily Dose) on the Incidence of Hypercalciuria in Subjets Aged From 2 to 18 Years (DonneDVit)
- Published
- 2023
27. Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
- Author
-
Indiana University School of Medicine, University of Chicago, and James Lingeman, James Lingeman, MD
- Published
- 2023
28. Bone Mineral Density and Vascular Calcifications in the Population of Lithiasis Patients With Idiopathic Hypercalciuria
- Author
-
Agnieszka Pozdzik, Head of Dialysis Department
- Published
- 2023
29. Comparison of the bone mineral density status of patients with kidney stones stratified by stone composition.
- Author
-
Cong, Xiaoming, Huang, Lili, Wang, Xingbo, Li, Liulin, Zhang, Xin, Chen, Xuehua, and Xu, Yan
- Abstract
Purpose: Bone loss has been found to occur frequently in patients with particular metabolic disorders that are likely associated with certain kidney stone composition. Thus, we compared the bone mineral density (BMD) of patients with different kidney stone compositions. Patients and methods: A total of 204 consecutive patients who exhibited stone formation with calcium oxalate (CaOx), calcium phosphate (CaP), uric acid (UA), and magnesium ammonium phosphate (MAP) underwent 24 h urine test and BMD measurement. BMD was measured by dual X-ray absorptiometry at the lumbar spine (LS) and femoral neck (FN). The Z-score was used to express BMD. A BMD Z-score ≤ − 2 was defined as a diagnostic threshold for bone loss. Results: Amongst the patients, 38 had an LS BMD Z-score of ≤ − 2, but only 2 had FN BMD Z-score of ≤ − 2. The group with an LS BMD Z-score of ≤ − 2 exhibited significantly larger male − female ratio, higher frequency of hypercalciuria and CaP, and lower frequency of MAP than the group with an LS BMD Z-score of > − 2. Reduced LS BMD was most remarkable in the CaP group, followed by the CaOx, UA, and MAP groups. The LS BMD Z-score of hypercalciuric patients was significantly lower than that of normocalciuric patients only in the CaP group. Conclusion: Patients with different kidney stone compositions presented different BMD status. Using this information may facilitate medical decision-making in patients with kidney stone who should undergone BMD earlier. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria.
- Author
-
Rodríguez, Daniel, Gurevich, Ekaterina, Jouabadi, Soroush Mohammadi, Arroyo, Eva Maria Pastor, Ritter, Alexander, Younes, Sandrine Estoppey, Wagner, Carsten A, Silva, Pedro Henrique Imenez, Seeger, Harald, and Mohebbi, Nilufar
- Subjects
- *
KIDNEY stones , *SCLEROSTIN , *CHOLECALCIFEROL , *KIDNEY development , *BONE growth - Abstract
Background Kidney stones are frequent in industrialized countries with a lifetime risk of 10 to 15%. A high percentage of individuals experience recurrence. Calcium-containing stones account for more than 80% of kidney stones. Diet, environmental factors, behavior, and genetic variants contribute to the development of kidney stones. Osteocytes excrete the 21 kDa glycoprotein sclerostin, which inhibits bone formation by osteoblasts. Animal data suggests that sclerostin might directly or indirectly regulate calcium excretion via the kidney. As hypercalciuria is one of the most relevant risk factors for kidney stones, sclerostin might possess pathogenic relevance in nephrolithiasis. Methods We performed a prospective cross-sectional observational controlled study in 150 recurrent kidney stone formers (rKSF) to analyse the association of sclerostin with known stone risk factors and important modulators of calcium-phosphate metabolism. Serum sclerostin levels were determined at the first visit. As controls, we used 388 non-stone formers from a large Swiss epidemiological cohort. Results Sclerostin was mildly increased in rKSF in comparison to controls. This finding was more pronounced in women compared to men. Logistic regression indicated an association of serum sclerostin with rKSF status. In hypercalciuric individuals, sclerostin levels were not different from normocalciuric patients. In Spearman correlation analysis we found a positive correlation between sclerostin, age, and BMI and a negative correlation with eGFR. There was a weak correlation with iPTH and intact FGF 23. In contrast, serum sclerostin levels were not associated with 25-OH Vitamin D3, 1,25-dihydroxy-Vitamin D3, urinary calcium and phosphate or other urinary lithogenic risk factors. Conclusion This is the first prospective controlled study investigating serum sclerostin in rKSF. Sclerostin levels were increased in rKSF independent of hypercalciuria and significantly associated with the status as rKSF. It appears that mechanisms other than hypercalciuria may be involved and thus further studies are required to elucidate underlying pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis (FHHNC): A Cross-sectional Study from Malaysia.
- Author
-
Bee Shuang Lee, Suet Li Yap, and Jia Ni Lee
- Subjects
CROSS-sectional method ,PUBLIC hospitals ,HYPERCALCIUREA ,EARLY medical intervention ,SCIENTIFIC observation ,EYE abnormalities ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,PEDIATRICS ,GENETIC disorders ,HYPOMAGNESEMIA ,KIDNEY calcification ,GENETIC mutation ,KIDNEY diseases ,EARLY diagnosis ,PHENOTYPES ,GENOTYPES ,MEMBRANE proteins ,DISEASE progression ,GENETIC testing - Abstract
Introduction: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare genetic disorder. There are few descriptions of phenotype and genotype in pediatric patients, especially from Asia. Methods: We retrospectively reviewed the records of 11 patients who were diagnosed with FHHNC due to a common homozygous mutation in CLDN19, the gene encoding claudin 19, in the state of Sarawak, Malaysia. Results: Eleven patients from eight families, predominantly of Iban descent, were diagnosed with FHHNC at a median age of 7 years. These patients had an identical novel homozygous pathogenic variant in CLDN19, c427del. Seven patients (63.7%) had ocular abnormalities. All patients had nephrocalcinosis; hypomagnesemia and hypocalcemia were seen in 10 and 6 cases, respectively. One patient was asymptomatic at diagnosis. Progression to kidney failure was seen in two patients, at 7 and 15 years of age. Conclusions: The finding of a common novel mutation in non consanguineous families from the Iban population across different regions in the Sarawak state suggests a founder effect, underscoring the importance of genetic screening in children from this region presenting with unexplained ocular symptoms or electrolyte abnormalities associated with nephrocalcinosis, to facilitate early diagnosis and management of FHHNC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Frequency of urinary metabolic abnormalities in children with renal stone disease.
- Author
-
Jehan, Serat, Ibrahim, Mohsina Noor, Khan, Shariq Anis, Abro, Bilquis, Moorani, Khemchand N., and Riaz, Mehwish
- Subjects
- *
KIDNEY stones , *URINALYSIS , *BILIOUS diseases & biliousness , *HUMAN abnormalities , *CHRONIC kidney failure , *CHOLANGITIS - Abstract
Objective: to determine how frequently children in developing countries like Pakistan with urolithiasis have metabolic abnormalities alongwith clinical features. Study Design: Descriptive Cross Sectional study. Setting: Department of Paediatric, National Institute of Child Health, Karachi. Period: January 2021 to February 2022. Material & Methods: To determine how frequently local children with urolithiasis have metabolic problems. A total of 80 children who were aged 4 to 14 years and who had renal stones were included, while those suffering from chronic kidney diseases, liver and biliary tract diseases and children, receiving vitamin D supplementation are excluded. Urine samples were analyzed urinary uric acid, calcium, Demographics and metabolic abnormalities--hypercalciuria, hyperuricosuria analyzed. Results: The study analysis included 80 patients. Seventy one patients (88.8%) had metabolic abnormalities. Most frequent metabolic abnormality was hypercalciuria 60(75%) followed by hyperuricosuria in 52(65%) of participants. There was no significant association observed between metabolic abnormalities and age, gender and BMI classification. Conclusion: Metabolic abnormalities were found 88.8% of children presenting with urinary lithiasis. The most frequent abnormality observed was hypercalciuria followed by hyperuricosuria. Early identification helps manage such patients appropriately, mitigating long-term sequelae. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Idiopathic Hypercalciuria - A Major Metabolic Risk for Calcium Kidney Stone Disease.
- Author
-
TANG, OLIVE W. and JIE TANG
- Subjects
- *
KIDNEY stones , *CALCIUM , *HYPOKINESIA - Abstract
Idiopathic hypercalciuria is defined as excessive urine calcium excretion in the absence of an identifiable cause. It has been strongly associated with the risk of calcium kidney stone formation. Animal and human studies have suggested excessive bone mineral loss or increased gastrointestinal calcium absorption with abnormal renal calcium excretion may contribute to this process. In this article we will review the complex pathophysiology of idiopathic hypercalciuria and discuss clinical management and challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2023
34. An overview of global research landscape in etiology of urolithiasis based on bibliometric analysis.
- Author
-
Dong, Caitao, Song, Chao, He, Ziqi, Liao, Wenbiao, Song, Qianlin, Xiong, Yunhe, Meng, Lingchao, and Yang, Sixing
- Abstract
The high incidence, recurrence and treatment costs of urolithiasis have a serious impact on patients and society. For a long time, countless scholars have been working tirelessly on studies related to the etiology of urolithiasis. A comprehensive understanding of the current status will be beneficial to the development of this field. We collected all literature about the etiology of urolithiasis from 1990 to 2022 using the Web of Science (WoS) database. VOSviewer, Bibliometrix and CiteSpace software were used to quantitatively analyze and visualize the data as well. The query identified 3177 articles for final analysis, of which related to the etiology of urolithiasis. The annual number of publications related to urolithiasis research has steadily increased during the latest decade. United States (1106) and China (449) contributed the most publications. University of Chicago (92) and Indiana University (86) have the highest number of publications. Urolithiasis and Journal of Urology have published the most articles in the field. Coe FL is the most productive author (63 articles), whose articles have obtained the most citations in all (4141 times). The keyword, such as hypercalciuria, hyperoxaluria, citrate, oxidative stress, inflammation, Randall’s plaque, are the most attractive targets for the researchers. Our review provides a global landscape of studies related to the etiology of urolithiasis, which can serve as a reference for future studies in this field. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Metabolic evaluation and stone analysis in cases of pediatric urolithiasis: A prospective study.
- Author
-
Janaki, K. L., S., Vidya Sagar, Devraj, Rahul, and Ch., Ram Reddy
- Subjects
- *
URINARY calculi , *KIDNEY stones , *LONGITUDINAL method , *CALCIUM oxalate , *CHILD patients - Abstract
Aim: This study aims to analyze the stones and evaluate for any metabolic cause in pediatric patients with urolithiasis. Materials and methods: A prospective observational study was done in the department of urology, NIMS, on 30 patients with urolithiasis. Results: Calcium oxalate stones were the most common type of stone found in patients with renal stones and ureteric stones discreetly. Hypercalciuria was the most prevalent metabolic abnormality found in this study. Conclusion: Owing to the high prevalence of metabolic risk factors and the significant risk of recurrence, all children with urolithiasis need complete evaluation with metabolic workup and ensure complete removal of stone. [ABSTRACT FROM AUTHOR]
- Published
- 2023
36. Renal Calculi
- Author
-
Kovacevic, Larisa, Goodyer, Paul, Schaefer, Franz, editor, and Greenbaum, Larry A., editor
- Published
- 2023
- Full Text
- View/download PDF
37. Disorders of Calcium and Magnesium Metabolism
- Author
-
Schlingmann, Karl Peter, Konrad, Martin, Schaefer, Franz, editor, and Greenbaum, Larry A., editor
- Published
- 2023
- Full Text
- View/download PDF
38. Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial
- Author
-
Lilit Sardari Masihi, Nasrin Borumandnia, Maryam Taheri, Abbas Basiri, Hossein Imani, Saba Jalali, and Sanaz Tavasoli
- Subjects
Vitamin D deficiency ,Urolithiasis ,24-h urine ,Hypercalciuria ,Medicine - Abstract
Abstract Objectives To evaluate the effects of two vitamin D repletion therapies (cholecalciferol) on serum levels of 25-hydroxyvitamin D (25(OH)D) and 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency (VDD). Design, setting, participants A parallel-group randomized controlled clinical trial on patients who referred to Labbafinejad kidney stone prevention clinic, Tehran, Iran. From 88 recurrent calcium stone formers, 62 patients completed the study. The age of participants was 18–70 years who had serum 25(OH)D levels of 10–20 ng/ml. Intervention Participants received oral cholecalciferol 2000 IU daily for 12 weeks or 50,000 IU weekly for 8 weeks. Main outcome measures Study variables including 24-h urine calcium, supersaturations of calcium oxalate and calcium phosphate, serum 25(OH)D and parathyroid hormone were measured at the beginning of the study and after 12 weeks. Results The 24-h urine calcium significantly increased in both groups (β = 69.70, p
- Published
- 2023
- Full Text
- View/download PDF
39. CYP24A1 Deficiency Mimicking Other Causes of Hypercalciuria and Nephrocalcinosis: A Case Report
- Author
-
Fernández-Sánchez, A., Cárdenas-Salas, J. J., Kelly, F. Blanco, Campos-Valverde, D., Bueno-Serrano, G., Alcoba-García, M. P., Pérez-Gomez, M. V., Peña-Sanchez, L., Porres-Cubero, A., Tabares, J. J., Barrio-Dorado, M. P., Roselló, M. G., Trujillo-Tiebas, M. J., and Vázquez, C.
- Published
- 2024
- Full Text
- View/download PDF
40. Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics.
- Author
-
Zung, Amnon, Barash, Galia, Banne, Ehud, and Levine, Michael A.
- Subjects
- *
CALCITRIOL , *HYPOCALCEMIA , *GENETIC mutation , *KIDNEY physiology , *STATISTICAL correlation , *KIDNEY stones , *CALCIUM-sensing receptors - Abstract
Introduction: Activating mutation of the calcium-sensing receptor gene (CASR) reduces parathyroid hormone secretion and renal tubular reabsorption of calcium, defined as autosomal dominant hypocalcemia type 1 (ADH1). Patients with ADH1 may present with hypocalcemia-induced seizures. Calcitriol and calcium supplementation in symptomatic patients may exacerbate hypercalciuria, leading to nephrocalcinosis, nephrolithiasis, and compromised renal function. Methods: We report on a family with seven members over three generations with ADH1 due to a novel heterozygous mutation in exon 4 of CASR: c.416T>C. Results: This mutation leads to substitution of isoleucine with threonine in the ligand-binding domain of CASR. HEK293T cells transfected with wild type or mutant cDNAs demonstrated that p.Ile139Thr substitution led to increased sensitivity of the CASR to activation by extracellular calcium relative to the wild-type CASR (EC50 of 0.88 ± 0.02 mM vs. 1.1 ± 0.23 mM, respectively, p < 0.005). Clinical characteristics included seizures (2 patients), nephrocalcinosis and nephrolithiasis (3 patients), and early lens opacity (2 patients). In 3 of the patients, serum calcium and urinary calcium-to-creatinine ratio levels obtained simultaneously over 49 patient-years were highly correlated. Using the age-specific maximal-normal levels of calcium-to-creatinine ratio in the correlation equation, we obtained age-adjusted serum calcium levels that are high enough to reduce hypocalcemia-induced seizures and low enough to reduce hypercalciuria. Conclusion: We report on a novel CASR mutation in a three-generation kindred. Comprehensive clinical data enabled us to suggest age-specific upper limit of serum calcium levels, considering the association between serum calcium and renal calcium excretion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
41. Unikatowe współistnienie mutacji genów SHOX i PTHLH u 12-letniego chłopca z syndromicznym niskim wzrostem. Opis przypadku z przeglądem literatury.
- Author
-
Sobieszczańska-Droździel, Aleksandra and Wojciechowska, Katarzyna
- Abstract
Copyright of Paediatrics & Family Medicine / Pediatria i Medycyna Rodzinna is the property of Medical Communications Sp. z o.o. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
42. Distal renal tubular acidosis as presenting manifestation of Wilson disease in a 11-year-old girl
- Author
-
Saiteja, Paraselli, Krishnamurthy, Sriram, Deepthi, Bobbity, Krishnasamy, Sudarsan, and Sravani, Madhileti
- Published
- 2024
- Full Text
- View/download PDF
43. The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation
- Author
-
Farai C. Gombedza, Samuel Shin, Jaclyn Sadiua, George B. Stackhouse, and Bidhan C. Bandyopadhyay
- Subjects
hypercalciuria ,renal tubular pH ,proximal tubule ,oxidative stress ,inflammation ,fibrosis ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
In calcium nephrolithiasis (CaNL), most calcium kidney stones are identified as calcium oxalate (CaOx) with variable amounts of calcium phosphate (CaP), where CaP is found as the core component. The nucleation of CaP could be the first step of CaP+CaOx (mixed) stone formation. High urinary supersaturation of CaP due to hypercalciuria and an elevated urine pH have been described as the two main factors in the nucleation of CaP crystals. Our previous in vivo findings (in mice) show that transient receptor potential canonical type 3 (TRPC3)-mediated Ca2+ entry triggers a transepithelial Ca2+ flux to regulate proximal tubular (PT) luminal [Ca2+], and TRPC3-knockout (KO; -/-) mice exhibited moderate hypercalciuria and microcrystal formation at the loop of Henle (LOH). Therefore, we utilized TRPC3 KO mice and exposed them to both hypercalciuric [2% calcium gluconate (CaG) treatment] and alkalineuric conditions [0.08% acetazolamide (ACZ) treatment] to generate a CaNL phenotype. Our results revealed a significant CaP and mixed crystal formation in those treated KO mice (KOT) compared to their WT counterparts (WTT). Importantly, prolonged exposure to CaG and ACZ resulted in a further increase in crystal size for both treated groups (WTT and KOT), but the KOT mice crystal sizes were markedly larger. Moreover, kidney tissue sections of the KOT mice displayed a greater CaP and mixed microcrystal formation than the kidney sections of the WTT group, specifically in the outer and inner medullary and calyceal region; thus, a higher degree of calcifications and mixed calcium lithiasis in the kidneys of the KOT group was displayed. In our effort to find the Ca2+ signaling pathophysiology of PT cells, we found that PT cells from both treated groups (WTT and KOT) elicited a larger Ca2+ entry compared to the WT counterparts because of significant inhibition by the store-operated Ca2+ entry (SOCE) inhibitor, Pyr6. In the presence of both SOCE (Pyr6) and ROCE (receptor-operated Ca2+ entry) inhibitors (Pyr10), Ca2+ entry by WTT cells was moderately inhibited, suggesting that the Ca2+ and pH levels exerted sensitivity changes in response to ROCE and SOCE. An assessment of the gene expression profiles in the PT cells of WTT and KOT mice revealed a safeguarding effect of TRPC3 against detrimental processes (calcification, fibrosis, inflammation, and apoptosis) in the presence of higher pH and hypercalciuric conditions in mice. Together, these findings show that compromise in both the ROCE and SOCE mechanisms in the absence of TRPC3 under hypercalciuric plus higher tubular pH conditions results in higher CaP and mixed crystal formation and that TRPC3 is protective against those adverse effects.
- Published
- 2024
- Full Text
- View/download PDF
44. Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial.
- Author
-
Sardari Masihi, Lilit, Borumandnia, Nasrin, Taheri, Maryam, Basiri, Abbas, Imani, Hossein, Jalali, Saba, and Tavasoli, Sanaz
- Subjects
VITAMIN D deficiency ,KIDNEY stones ,CLINICAL trials ,VITAMIN D ,CALCIUM oxalate - Abstract
Objectives: To evaluate the effects of two vitamin D repletion therapies (cholecalciferol) on serum levels of 25-hydroxyvitamin D (25(OH)D) and 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency (VDD). Design, setting, participants: A parallel-group randomized controlled clinical trial on patients who referred to Labbafinejad kidney stone prevention clinic, Tehran, Iran. From 88 recurrent calcium stone formers, 62 patients completed the study. The age of participants was 18–70 years who had serum 25(OH)D levels of 10–20 ng/ml. Intervention: Participants received oral cholecalciferol 2000 IU daily for 12 weeks or 50,000 IU weekly for 8 weeks. Main outcome measures: Study variables including 24-h urine calcium, supersaturations of calcium oxalate and calcium phosphate, serum 25(OH)D and parathyroid hormone were measured at the beginning of the study and after 12 weeks. Results: The 24-h urine calcium significantly increased in both groups (β = 69.70, p < 0.001), with no significant difference between treatments. Both groups showed no significant change in the supersaturation levels of calcium oxalate and calcium phosphate. Serum levels of 25(OH)D increased significantly (β = 12.53, p < 0.001), with more increase in the 50,000 IU group (β = 3.46, p = 0.003). Serum parathyroid hormone decreased in both groups (p < 0.001). Conclusions: Although both treatment protocols increased 24-h urine calcium, they did not increase the supersaturation state of calcium oxalate or calcium phosphate. Trial registration IRCT20160206026406N4, 13/08/2019. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. A path analysis to investigate the interaction between serum, urinary and demographic factors influencing urine calcium in kidney stone formers.
- Author
-
Taheri, Fatemeh, Taheri, Maryam, Tavasoli, Sanaz, Basiri, Abbas, and Borumandnia, Nasrin
- Abstract
Background: Hypercalciuria is one of the most important urinary risk factors in kidney stone formers. This study aimed to delineate the interaction of some demographic, serum, and urinary risk factors influencing 24-h urinary (24-U) calcium excretion. Methods: This study was secondary data analysis, using data from 593 kidney stone patients referred to the Labbafinejad kidney stone prevention clinic from March 2015 to May 2019. The study considered serum, urinary and demographic factors that interact to influence 24-U calcium using path analysis. In addition to the direct impact of predictors on the 24-U calcium, this analysis considered the effects of the predictors on the 24-U calcium transmitted by a mediating variable named indirect effects. Results: The results showed that age indirectly affected on 24-U calcium through 25-hydroxy vitamin D (25(OH)D), serum and 24-U creatinine. As well, weight had an indirect effect through 24-urine metabolites (creatinine, citrate, urea, and sodium). Among serum variables, PTH and creatinine significantly directly affected on 24-U calcium. In comparison, 25(OH)D and phosphorus appeared to influence 24-U calcium indirectly through serum parathormone. Regarding 24-U metabolites, sodium, urea, and citrate had a significant direct effect on 24-U calcium. Moreover, 24-U creatinine has a significant direct and indirect effect on 24-U calcium through citrate and urea as mediator variables. Conclusion: Serum 25(OH)D and phosphorus, along with age and weight, indirectly affected urinary calcium through a third variable. Other variables (PTH, serum creatinine, and 24-U sodium, urea, and citrate) showed a direct effect on 24-U calcium excretion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Autosomal Dominant Hypocalcemia Type 1 and Neonatal Focal Seizures.
- Author
-
Teleanu, Raluca Ioana, Sarman, Marlene Alexandra, Epure, Diana Anamaria, Matei, Margarita, Roşca, Ioana, and Roza, Eugenia
- Subjects
TREATMENT of epilepsy ,DIAGNOSIS of epilepsy ,ANTICONVULSANTS ,GENETIC mutation ,ELECTROENCEPHALOGRAPHY ,ALCOHOL dehydrogenase ,CHOLECALCIFEROL ,HYPOPARATHYROIDISM ,VITAMIN D ,HYPOCALCEMIA ,CALCIUM-binding proteins ,CALCIUM ,HYPERCALCIUREA ,CHILDREN - Abstract
Autosomal dominant hypocalcemia type 1 (ADH1) is a rare form of hypoparathyroidism that is characterized by gain-of-function mutations in the CASR gene, which provides instructions for producing the protein called calcium-sensing receptor (CaSR). Hypocalcemia in the neonatal period has a wide differential diagnosis. We present the case of a female newborn with genetic hypoparathyroidism (L125P mutation of CASR gene), hypocalcemia, and neonatal seizures due to the potential correlation between refractory neonatal seizures and ADH1. Neonatal seizures were previously described in patients with ADH1 but not in association with the L125P mutation of the CASR gene. Prompt diagnosis and management by a multidisciplinary and an appropriate therapeutic approach can prevent neurological and renal complications. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Refractory hypercalcemia of malignancy: a problem with many potential roots.
- Author
-
Farooki, Azeez
- Subjects
HYPERCALCEMIA ,HOSPITAL admission & discharge ,PARATHYROID hormone-related protein ,REFRACTORY materials - Abstract
Hypercalcemia of malignancy (HCM) is a common clinical problem that is associated with considerable morbidity and negative effects on quality of life. Despite the availability of effective medical treatments for HCM, options are needed for cases that are refractory to conventional therapies. In this context, "refractory" refers to reasonable control of calcium in the setting of inpatient hospitalization (after receipt of standard of care therapies, such as continuous intravenous fluids, calcitonin, and intravenous bisphosphonates) with relapse into severe hypercalcemia within days or weeks of discharge from the hospital. Here we discuss drivers of hypercalcemia of malignancy and the physiologic mechanisms whereby they operate to increase serum calcium. Additionally, we discuss multiple available treatments targeted to a given contributory mechanism and also briefly discuss potential future treatments in need of further study. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI.
- Author
-
Seale, Emily, Molina, Maria Ochoa, Carsen, Sasha, Sheffield, Holden, Koujok, Khaldoun, Robinson, Marie-Eve, Feber, Janusz, Smit, Kevin, Page, Marika, Walker, Scott, Khan, Nasrin, Konji, Victor N., Rauch, Frank, and Ward, Leanne M.
- Subjects
- *
OSTEOGENESIS imperfecta , *DENOSUMAB , *ZOLEDRONIC acid , *HYPERCALCEMIA , *PARATHYROID hormone - Abstract
Osteogenesis imperfecta (OI) type VI, a recessively inherited form of OI caused by mutations in SERPINF1, is a severe form distinguished by osteomalacia on bone histomorphometry. We describe a boy with severe OI type VI who was initially treated with intravenous (IV) zoledronic acid (ZA) at 1.4 years of age; however, a year later he transitioned to denosumab 1 mg/kg sub-cutaneously every three months in an effort to decrease fracture rates. After two years on denosumab, he presented with symptomatic hypercalcemia due to the denosumab-induced, hyper-resorptive rebound phenomenon. Laboratory parameters at the time of the rebound were as follows: elevated serum ionized calcium (1.62 mmol/L, N 1.16–1.36), elevated serum creatinine due to hypercalcemia-induced muscle catabolism (83 µmol/L, N 9–55), and suppressed parathyroid hormone (PTH) (< 0.7 pmol/L, N 1.3–5.8). The hypercalcemia was responsive to low-dose IV pamidronate, with a rapid decline in serum ionized calcium, and otherwise normalization of the aforementioned parameters within 10 days. To benefit from the powerful, albeit short-term, anti-resorptive effect of denosumab without further rebound episodes, he was treated thereafter with denosumab 1 mg/kg alternating every three months with IV ZA 0.025 mg/kg. Five years later, he remained on dual alternating anti-resorptive therapy without further rebound episodes, and an overall improvement in his clinical status. This novel pharmacological approach of alternating short- and long-term anti-resorptive therapy every three months has not previously been described. Our report suggests this strategy may be an effective method for prevention of the rebound phenomenon in select children for whom denosumab may be beneficial. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. 云南德宏州傣族人群 CaSR 基因 SNP 与含钙肾结石和 高钙尿的关联性.
- Author
-
李吉, 柯坤彬, 张白羽, 刘裔道, 白晶, 董滔, 王振丞, 秦德强, 王梦悦, and 李颢
- Abstract
Objective: To study the association of CaSR gene polymorphism with calcium nephrolithiasis and hypercalciuria in Chinese Dai population. Methods: The Dai patients with calcium containing renal calculi in Dehong Prefecture, Yunnan Province, China were selected as the experimental group, and the healthy Dai people in Dehong Prefecture, Yunnan Province were taken as the control group. The venous blood was drawn for the determination of the three SNP loci rs7652589, rs1801725, and rs1042636 of the CaSR gene. The subjects in the stone group were tested for 24-hour urine calcium value, and the gene correlation was analyzed. Results: There was a statistical difference between the homozygous AA gene and AA+GG gene at rs7652589 locus in the occurrence of calcium nephrolithiasis (P < 0.05). The 24 h urine calcium value of the GG genotype with rs1042636 locus was significantly different from that of the AA based and AG genotype (P < 0.05). There was a significant difference in 24 h urine calcium between those with GG genotype at rs7652589 locus and those with AA and AG genotype (P < 0.05) Conclusion The rs7652589 polymorphism on the CaSR gene in the Dai population in China is related to the occurrence of calcium nephrolithiasis and hypercalciuria. The GG gene at rs1042636 is related to the occurrence of hypercalciuria in the Dai population. The GG gene at rs7652589 may be a candidate gene for the occurrence of hypercalciuria leading to calcium nephrolithiasis in this ethnic group. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. Activating calcium-sensing receptor gene variants in China: a case report of hypocalcaemia and literature review.
- Author
-
Guo, Shuzhen, Li, Xiaolin, and Shan, Xiaoou
- Abstract
Autosomal dominant hypocalcaemia 1 (ADH1) is a rare autosomal dominant genetic disease, due to the activating mutations of the calcium-sensing receptor (CASR) gene. The current paper presents a severe case of ADH1 with intellectual backwardness, and systematically reviews the reported 17 ADH1 patients in China. A 7 years old boy with recurrent seizures over 1 year was admitted at Yuying children' hospital, the clinical centre of south province of Zhejiang. Auxiliary examinations demonstrated hypocalcaemia, hyperphosphatemia, hypomagnesemia, hypercalciuria, low parathyroid hormone (PTH), basal ganglia calcifications, normal range of serum creatinine, and 25-hydroxyvitamin D. Wechsler's intelligence test result indicated intellectually backward. The patient's genotype found a heterozygous variant in CASR gene, c.T416C p. (Ile139Thr). This article also systematically reviews the literatures on ADH1 in China and summarises the clinical characteristics and treatment. ADH1 can be a cause of idiopathic hypoparathyroidism. Recognition and rational treatment is important for symptom improvement and reducing high potential adverse effects. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.